Emerald Mutual Fund Advisers Trust’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,386
| Closed | -$1.36M | – | 231 |
|
|
2025
Q1 | $1.36M | Buy |
21,386
+2,286
| +12% | +$241K | 0.1% | 124 |
|
|
2024
Q4 | $2.32M | Buy |
19,100
+18,082
| +1,776% | +$2.22M | 0.14% | 115 |
|
|
2024
Q3 | $127K | Buy |
+1,018
| New | +$141K | 0.01% | 210 |
|
|
2023
Q1 | – | Sell |
-2,097
| Closed | -$272K | – | 263 |
|
|
2022
Q4 | $272K | Sell |
2,097
-432
| -17% | -$50.1K | 0.02% | 167 |
|
|
2022
Q3 | $280K | Buy |
+2,529
| New | +$255K | 0.02% | 175 |
|
|
2021
Q1 | – | Sell |
-1,287
| Closed | -$219K | – | 243 |
|
|
2020
Q4 | $219K | Hold |
1,287
| – | – | 0.01% | 209 |
|
|
2020
Q3 | $181K | Sell |
1,287
-21
| -2% | -$3.19K | 0.01% | 242 |
|
|
2020
Q2 | $210K | Buy |
+1,308
| New | +$178K | 0.01% | 231 |
|
|
2020
Q1 | – | Sell |
-1,767
| Closed | -$228K | – | 301 |
|
|
2019
Q4 | $228K | Buy |
+1,767
| New | +$178K | 0.01% | 207 |
|
|
2019
Q2 | – | Sell |
-40,842
| Closed | -$4.87M | – | 215 |
|
|
2019
Q1 | $4.87M | Sell |
40,842
-15,450
| -27% | -$1.99M | 0.2% | 145 |
|
|
2018
Q4 | $6.14M | Sell |
56,292
-159,602
| -74% | -$20M | 0.29% | 123 |
|
|
2018
Q3 | $34.9M | Sell |
215,894
-28,091
| -12% | -$3.84M | 1.18% | 11 |
|
|
2018
Q2 | $32.3M | Sell |
243,985
-82,757
| -25% | -$7.8M | 1.17% | 12 |
|
|
2018
Q1 | $24.2M | Sell |
326,742
-374,486
| -53% | -$25M | 0.95% | 21 |
|
|
2017
Q4 | $39M | Sell |
701,228
-15,544
| -2% | -$823K | 1.55% | 4 |
|
|
2017
Q3 | $32.5M | Buy |
716,772
+38,502
| +6% | +$1.54M | 1.36% | 8 |
|
|
2017
Q2 | $22.9M | Buy |
678,270
+73,803
| +12% | +$2.4M | 1% | 24 |
|
|
2017
Q1 | $17.9M | Buy |
604,467
+201,942
| +50% | +$6.25M | 0.82% | 39 |
|
|
2016
Q4 | $11M | Buy |
402,525
+136,230
| +51% | +$5.47M | 0.53% | 72 |
|
|
2016
Q3 | $16.4M | Buy |
266,295
+19,209
| +8% | +$581K | 0.83% | 39 |
|
|
2016
Q2 | $4.71M | Buy |
+247,086
| New | +$4.58M | 0.26% | 121 |
|
|
2015
Q4 | – | Sell |
-322,970
| Closed | -$10.4M | – | 294 |
|
|
2015
Q3 | $10.4M | Buy |
322,970
+59,450
| +23% | +$2.02M | 0.68% | 56 |
|
|
2015
Q2 | $8.02M | Buy |
+263,520
| New | +$5.39M | 0.62% | 65 |
|
|
2014
Q4 | – | Sell |
-217,693
| Closed | -$4.59M | – | 224 |
|
|
2014
Q3 | $4.59M | Sell |
217,693
-5,740
| -3% | -$130K | 0.44% | 84 |
|
|
2014
Q2 | $6.66M | Buy |
223,433
+41,579
| +23% | +$1.31M | 0.61% | 63 |
|
|
2014
Q1 | $4.37M | Sell |
181,854
-250,564
| -58% | -$6.39M | 0.42% | 87 |
|
|
2013
Q4 | $9.73M | Buy |
432,418
+253,584
| +142% | +$7.54M | 0.58% | 69 |
|
|
2013
Q3 | $8.45M | Buy |
178,834
+800
| +0.4% | +$30.8K | 1.17% | 21 |
|
|
2013
Q2 | $6.77M | Buy |
+178,034
| New | +$6.37M | 1.15% | 27 |
|
Other funds holding SRPT
EAM
Emerald Mutual Fund Advisers Trust's SRPT Position: Q2 2025 in Review
Emerald Mutual Fund Advisers Trust sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 21,386 shares — an estimated $1.36M sold.
Emerald Mutual Fund Advisers Trust first reported a position in SRPT in Q2 2013 and held it in 29 quarters. The position peaked at $39M in Q4 2017. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.
- Emerald Mutual Fund Advisers Trust reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 21,386 Sarepta Therapeutics shares in Q2 2025, an estimated $1.36M.
- Emerald Mutual Fund Advisers Trust first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 29 quarters.
- Emerald Mutual Fund Advisers Trust's Sarepta Therapeutics position peaked at $39M in Q4 2017.
- 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2025, filed 4 Aug 2025.